SCHEMBL1726870

SCHEMBL1726870

O=C(c1ccnc(Cl)c1)N(O)c1cccc(C(F)(F)F)c1C1CCN(Cc2ccc(-c3ccc(Cl)cc3)cc2)CC1.O=S(=O)(O)CCCO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LSS P48449 1/20 0.34
CHRM2 P08172 2/20 0.33
CHRM3 P20309 2/20 0.33
UBE2M P61081 1/20 0.33
DCUN1D1 Q96GG9 1/20 0.33
CCR2 P41597 1/20 0.33
SCN1A P35498 1/20 0.33
SCN8A Q9UQD0 1/20 0.33
FAAH O00519 2/20 0.33
CHRM4 P08173 1/20 0.33
WNK1 Q9H4A3 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MCHR1 Q99705 1/20 0.32
KCNH2 Q12809 1/20 0.32
S1PR1 P21453 1/20 0.32
CNR1 P21554 1/20 0.32
SLC9A1 P19634 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1726750 0.76 MEN1 (0.48) UBE2MDCUN1D1CCR2MCHR1MEN1
SCHEMBL1725571 0.75 DRD2 (0.38) LSSUBE2MDCUN1D1CCR2FAAH
SCHEMBL1726868 0.73 UBE2M (0.35) CHRM2CHRM3UBE2MDCUN1D1CCR2
SCHEMBL1844021 0.71 WNK1 (0.43) LSSUBE2MDCUN1D1CCR2WNK1
SCHEMBL1844023 0.68 MEN1 (0.53) LSSUBE2MDCUN1D1CHRM4MEN1
SCHEMBL1727312 0.62 MCHR1 (0.44) CHRM4MCHR1KCNH2MEN1LMNA
SCHEMBL12153529 0.62 MCHR1 (0.44) CHRM4MCHR1KCNH2MEN1LMNA
SCHEMBL12153544 0.61 MCHR1 (0.43) CHRM4MCHR1KCNH2MEN1LMNA
SCHEMBL12153653 0.61 MCHR1 (0.44) UBE2MDCUN1D1CCR2MCHR1MEN1
SCHEMBL5577706 0.60 PROKR1 (0.52) CHRM4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10034476-B2 Insecticidal phenyl-or pyridyl-piperdine compounds SYNGENTA PARTICIPATIONS AG (CH) 2018-07-31 US disclosed
US-20170347650-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2017-12-07 US disclosed
US-9808006-B2 Insecticidal phenyl-or pyridyl-piperdine compounds SYNGENTA PARTICIPATIONS AG (CH) 2017-11-07 US disclosed
US-20130317062-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2013-11-28 US disclosed
US-8518971-B2 Insecticidal phenyl- or pyridyl-piperdine compounds SYNGENTA CROP PROTECTION, INC. (US) 2013-08-27 US disclosed
WO-2012037282-A3 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS NOVOMER, INC. (US) 2012-05-10 WO disclosed
EP-2324010-B1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERIDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2011-11-30 EP disclosed
US-20110136866-A1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA CROP PROTECTION LLC (US) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10034476-B2 Insecticidal phenyl-or pyridyl-piperdine compounds ACHE, CHRM1, CHRM2 LSS 3226/4885CHRM2 3/4885CHRM3 10/4885
US-20130317062-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 LSS 3226/4885CHRM2 3/4885CHRM3 10/4885
US-20110136866-A1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 LSS 3190/4885CHRM2 3/4885CHRM3 9/4885
US-20170347650-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 LSS 3226/4885CHRM2 3/4885CHRM3 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.